These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 19375869

  • 1. Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls.
    Carpenter LL, Ross NS, Tyrka AR, Anderson GM, Kelly M, Price LH.
    Psychoneuroendocrinology; 2009 Sep; 34(8):1208-13. PubMed ID: 19375869
    [Abstract] [Full Text] [Related]

  • 2. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ.
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [Abstract] [Full Text] [Related]

  • 3. Can the DEX/CRH test or markers of oxidative stress distinguish work-related stress from major depressive disorder and normal controls?
    Rotvig DH, Jorgensen A, Jensen JH, Hansen AR, Eller NH, Jonsson SH, Knorr U, Klose MC, Feldt-Rasmussen U, Menke A, Poulsen HE, Bauer JØ, Jørgensen MB.
    Stress; 2024 Jan; 27(1):2353781. PubMed ID: 38823417
    [Abstract] [Full Text] [Related]

  • 4. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS, Cetinkalp S, Tunay S, Polat I, Simsek F, Aksoy B, Kizilates G, Erdogan Y, Coburn KL.
    J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
    [Abstract] [Full Text] [Related]

  • 5. Discrimination between patients with melancholic depression and healthy controls: comparison between 24-h cortisol profiles, the DST and the Dex/CRH test.
    Paslakis G, Krumm B, Gilles M, Schweiger U, Heuser I, Richter I, Deuschle M.
    Psychoneuroendocrinology; 2011 Jun; 36(5):691-8. PubMed ID: 21035272
    [Abstract] [Full Text] [Related]

  • 6. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 7. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.
    Rybakowski JK, Twardowska K.
    J Psychiatr Res; 1999 Oct; 33(5):363-70. PubMed ID: 10504004
    [Abstract] [Full Text] [Related]

  • 8. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G, Mathé AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P.
    Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
    [Abstract] [Full Text] [Related]

  • 9. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R.
    Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 11. The dexamethasone corticotropin releasing hormone test in healthy and depressed women with and without childhood adversity.
    Spitzer C, Otte C, Kuehl LK, May A, Schultebraucks K, Hellmann-Regen J, Wingenfeld K.
    Psychoneuroendocrinology; 2018 Jan; 87():147-151. PubMed ID: 29080551
    [Abstract] [Full Text] [Related]

  • 12. Childhood parental loss and adult hypothalamic-pituitary-adrenal function.
    Tyrka AR, Wier L, Price LH, Ross N, Anderson GM, Wilkinson CW, Carpenter LL.
    Biol Psychiatry; 2008 Jun 15; 63(12):1147-54. PubMed ID: 18339361
    [Abstract] [Full Text] [Related]

  • 13. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
    Rinne T, de Kloet ER, Wouters L, Goekoop JG, DeRijk RH, van den Brink W.
    Biol Psychiatry; 2002 Dec 01; 52(11):1102-12. PubMed ID: 12460693
    [Abstract] [Full Text] [Related]

  • 14. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study.
    Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M.
    J Psychiatr Res; 2001 Dec 01; 35(2):83-94. PubMed ID: 11377437
    [Abstract] [Full Text] [Related]

  • 15. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C, Baghai T, Zwanzger P, Minov C, Padberg F, Rupprecht R.
    J Psychiatr Res; 2001 Dec 01; 35(4):239-47. PubMed ID: 11578642
    [Abstract] [Full Text] [Related]

  • 16. The neuroendocrinology of childhood trauma in personality disorder.
    Lee RJ, Hempel J, Tenharmsel A, Liu T, Mathé AA, Klock A.
    Psychoneuroendocrinology; 2012 Jan 01; 37(1):78-86. PubMed ID: 21641725
    [Abstract] [Full Text] [Related]

  • 17. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.
    Behnken A, Bellingrath S, Symanczik JP, Rieck MJ, Zavorotnyy M, Domschke K, Arolt V, Zwanzger P.
    Psychoneuroendocrinology; 2013 Mar 01; 38(3):447-54. PubMed ID: 22840287
    [Abstract] [Full Text] [Related]

  • 18. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
    Psychoneuroendocrinology; 2012 Aug 01; 37(8):1199-208. PubMed ID: 22277728
    [Abstract] [Full Text] [Related]

  • 19. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.
    Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470
    [Abstract] [Full Text] [Related]

  • 20. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
    Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.